Post by shimmie on Nov 1, 2007 19:14:53 GMT -5
BLADDER STUDY SEEKS PARTICIPANTS
A medical research study is now underway to determine if an investigational medication is safe and effective for reducing the frequency of urinary incontinent episodes in individuals with MS or spinal cord injury (SCI).
For the over 400,000 people with MS in the United States, incontinence due to overactive bladder (OAB) is one of the most common problems that affect their daily lives. Statistics indicate that between 50 and 80 percent of people with MS experience this condition, with no differentiation between those with minimal MS symptoms and those with major impairments. However, the exact prevalence of urinary problems is not known because the onset is insidious, and if the symptoms are mild, they are often ignored. Sometimes, a person will reduce fluid intake in an attempt to self-manage this symptom. However, this can actually increase the risk of bladder problems.
The DignityToo Study is now underway to determine the safety and efficacy of an investigational medication that may help in reducing the frequency of incontinent episodes in both men and women who have MS or a SCI. This study is an important step in researching how to help manage incontinence in individuals who have had little or no success with traditional treatment options, including prescription medications, surgery and self-catheterization.
The DignityToo Study is presently taking place across the U.S. and in cities worldwide. Qualified participants are adults who have MS with an Expanded Disability Status Scale (EDSS) between 7.0 and 8.0 that essentially restricts them to a wheelchair, or a SCI between the C5 and C8 vertebrae. These individuals experience frequent incontinent episodes due to OAB, may be using self-catheterization to manage their bladder, and are looking for alternative treatment options. Investigational study medication, medical exams, and lab tests will be provided to qualified participants at no charge. Financial compensation for time and travel may also be available. For more information on the DignityToo Study and how to participate, ask your physician or visit www.DignityTooStudy.com to learn more and find locations of participating physicians.
A medical research study is now underway to determine if an investigational medication is safe and effective for reducing the frequency of urinary incontinent episodes in individuals with MS or spinal cord injury (SCI).
For the over 400,000 people with MS in the United States, incontinence due to overactive bladder (OAB) is one of the most common problems that affect their daily lives. Statistics indicate that between 50 and 80 percent of people with MS experience this condition, with no differentiation between those with minimal MS symptoms and those with major impairments. However, the exact prevalence of urinary problems is not known because the onset is insidious, and if the symptoms are mild, they are often ignored. Sometimes, a person will reduce fluid intake in an attempt to self-manage this symptom. However, this can actually increase the risk of bladder problems.
The DignityToo Study is now underway to determine the safety and efficacy of an investigational medication that may help in reducing the frequency of incontinent episodes in both men and women who have MS or a SCI. This study is an important step in researching how to help manage incontinence in individuals who have had little or no success with traditional treatment options, including prescription medications, surgery and self-catheterization.
The DignityToo Study is presently taking place across the U.S. and in cities worldwide. Qualified participants are adults who have MS with an Expanded Disability Status Scale (EDSS) between 7.0 and 8.0 that essentially restricts them to a wheelchair, or a SCI between the C5 and C8 vertebrae. These individuals experience frequent incontinent episodes due to OAB, may be using self-catheterization to manage their bladder, and are looking for alternative treatment options. Investigational study medication, medical exams, and lab tests will be provided to qualified participants at no charge. Financial compensation for time and travel may also be available. For more information on the DignityToo Study and how to participate, ask your physician or visit www.DignityTooStudy.com to learn more and find locations of participating physicians.